Janus kinase-2 inhibitor fedratinib in patients with myelofibrosis previously treated with ruxolitinib (JAKARTA-2): a single-arm, open-label, non-randomised, phase 2, multicentre study
Titel:
Janus kinase-2 inhibitor fedratinib in patients with myelofibrosis previously treated with ruxolitinib (JAKARTA-2): a single-arm, open-label, non-randomised, phase 2, multicentre study
Auteur:
Harrison, Claire N Schaap, Nicolaas Vannucchi, Alessandro M Kiladjian, Jean-Jacques Tiu, Ramon V Zachee, Pierre Jourdan, Eric Winton, Elliott Silver, Richard T Schouten, Harry C Passamonti, Francesco Zweegman, Sonja Talpaz, Moshe Lager, Joanne Shun, Zhenming Mesa, Ruben A